Parallax Volatility Advisers
DNA icon

Parallax Volatility Advisers’s Ginkgo Bioworks DNA Stock Holding History

Parallax Volatility Advisers’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,496
Closed -$186K – 2350
2023
Q2 		$186K Buy
2,496
+3
+0.1% +$178 ﹤0.01% 1900
2023
Q1 		$133K Sell
2,493
-231
-8% -$14.6K ﹤0.01% 2076
2022
Q4 		$184K Buy
+2,724
New +$251K ﹤0.01% 2162
2022
Q1 		– Sell
-755
Closed -$251K – 2977
2021
Q4 		$251K Buy
+755
New +$359K ﹤0.01% 2400

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Parallax Volatility Advisers's DNA Position: Q3 2023 in Review

Parallax Volatility Advisers sold out of Ginkgo Bioworks (DNA) in Q3 2023, closing a stake of 2,496 shares — an estimated $186K sold.

Parallax Volatility Advisers first reported a position in DNA in Q4 2021 and held it in 4 quarters. The position peaked at $251K in Q4 2021. 348 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

  • Parallax Volatility Advisers reported no remaining Ginkgo Bioworks position as of Q3 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,496 Ginkgo Bioworks shares in Q3 2023, an estimated $186K.
  • Parallax Volatility Advisers first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 4 quarters.
  • Parallax Volatility Advisers's Ginkgo Bioworks position peaked at $251K in Q4 2021.
  • 348 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Parallax Volatility Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.